Sudo Biosciences
PrivateLast Round
Series B
Feb 13, 2024
Total Funding Raised
$218M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sudo Biosciences is a biopharmaceutical company that develops innovative medicines targeting the TYK2 pseudokinase domain to treat immune-mediated inflammatory conditions, including multiple sclerosis and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sudo Biosciences Comparables
Compare Sudo Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lynk Pharmaceuticals | 88% | |
| Neuron23 | 86% | |
| Alumis | 79% | |
Sudo Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 13, 2024 | ||||
| Series B | Dec 20, 2023 | ||||
| Series A | Sep 28, 2022 | ||||
| Seed | Dec 31, 2020 |
Sudo Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Enavate Sciences | Series B |
| Surveyor Capital | Series B |
| Frazier Healthcare Partners | Series A |
| SV Health Investors | Series B |
| Northern Trust | Series B |
| Eventide Funds | Series B |
| Monograph Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 232% MoM.
- Dec 4, 2025
Paul S. Bavier appointed as Chief Legal Officer.
Sudo Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sudo Biosciences's valuation, stock price, and market status.